# Bleomycin

## BLEOCIN inj 15mg

##### 臨採

| TAH Drug Code      | [IBLE1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IBLE1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Skin cancer, head and neck cancer (maxillary cancer, tongue cancer, lip cancer, pharyngeal cancer, laryngeal cancer, oral cancer, etc.), lung cancer (primary or metastatic squamous cell carcinoma), esophageal cancer, malignant lymphoma (lymphosarcoma, Hodgkin's disease, etc.).                                                                                                                                                                                                                                                                                                                 |
| Dosing             | 15-30 mg IV, IM or SC twice weekly; 5-15 mg IA twice weekly.May adjust dosing frequency to once daily to once weekly.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Severe pulmonary, renal or cardiac dysfunction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Severe interstitial pneumonia & pulmonary fibrosis, hypersensitivity, fever, haemorrhage, scleroderma-like changes in skin, anorexia, diarrhea, GI upsets; renal, urinary & neuropsychic disturbances, hypertrophy of venous wall, narrowing of venous lumen & induration around administration site. Phlebalgia with IV administration. Dermatologic: Alopecia (1-10%), Skin reaction - finding, Erythema, rash, striae, vesiculation, hyperpigmentation, skin tenderness (50%) Endocrine metabolic: Shivering Gastrointestinal: Nausea and vomiting, Stomatitis Psychiatric: Confusion Other: Fever |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/bleomycin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

